NCM · Medical - Devices

HYPD (HYPD) Stock

$2.64 -0.75% NCM: HYPD Healthcare

Valuation

MetricValue
Price$2.64
Market Cap$13.17M
P/E Ratio-0.40
P/B Ratio0.46
P/S Ratio18.09
EPS (TTM)$-9.40
52-Week High$17.18
52-Week Low$2.49
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-109.76%
ROA-86.54%
ROCE-46.34%
Gross Margin-1900.00%
Operating Margin-1900.00%
Net Margin-31.63%
Debt/Equity0.16
Current Ratio2.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$14.0M$0$0$0$1.0M
Operating Profit$-13.0M$-27.0M$-25.0M$-49.0M$-19.0M
Net Profit$-13.0M$-28.0M$-27.0M$-50.0M$-45.0M
EPS$-39.20$-66.40$-53.15$-59.81$-9.40
Op Margin-93.0%-670885.8%-85004.6%-2333.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$32.0M$31.0M$29.0M$4.0M$52.0M
Total Liabilities$11.0M$14.0M$20.0M$17.0M$11.0M
Cash$19.0M$23.0M$15.0M$2.0M$6.0M
Borrowings$7.0M$10.0M$16.0M$11.0M$9.0M

Latest News

Hyperion Deploys 500,000 HYPE to Back Skew’s HIP-3 Market Push CryptoProwl · Jul 16, 2026 Hyperion DeFi Taps Blockdaemon to Expand Hyperliquid Staking Infrastructure CryptoProwl · Jun 22, 2026 Hyperion CEO Says HYPE Rally Still Undervalues Hyperliquid’s Ecosystem Shift CryptoProwl · Jun 18, 2026 Chardan Adjusts Hyperion DeFi Price Target to $7.30 From $8.25, Maintains Buy Rating MT Newswires · Jun 8, 2026 Hyperion DeFi Inc (HYPD) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Token Volatility GuruFocus.com · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-25.0M$-24.0M$-30.0M$-15.0M
Investing Cash Flow$-3.0M$-2.0M$-8.0M$0$-72.0M
Financing Cash Flow$2.0M$-1.0M$-1.0M$-3.0M$0
Net Cash Flow$-1.0M$-4.0M$-8.0M$-13.0M$4.0M
Free Cash Flow$-22.0M$-26.0M$-28.0M$-30.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield-402.68%
Quick Ratio1.97
Interest Coverage-9.50
Return 1Y-76.56%
Return 3Y-98.45%
Return 5Y-99.17%

Ownership

Insiders Held14.10%
Institutions Held11.39%
Institutions Float Held13.26%
Institutional HolderSharesReport Date
Lasry, Marc240,1242025-09-30
Morgan Stanley237,9862026-03-31
Redwood Wealth Management Group, LLC183,2732026-03-31
Jane Street Group, LLC128,2802026-03-31
Renaissance Technologies, LLC115,6412026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About HYPD

HYPD is led by CEO Hyunsu Jung, employs 13 people, headquartered in US, publicly traded since 2025.

HYPD stock trades at $2.64 with a market capitalization of $13.17M. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of 0.46, price-to-sales of 18.09. Over the past 52 weeks the stock has ranged between $2.49 and $17.18, and currently trades 84.6% below its 52-week high.

On profitability, HYPD generates a return on equity (ROE) of -109.76%, return on capital employed of -46.34%, an operating margin of -1900.00%, a net profit margin of -31.63%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides